BlackRock Fund Advisors - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 15 filers reported holding HISTOGENICS CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q4 2016$4,000
-33.3%
2,489
+27.7%
0.00%
Q3 2016$6,000
-57.1%
1,949
-75.9%
0.00%
Q2 2016$14,000
-61.1%
8,073
-49.3%
0.00%
Q1 2016$36,000
-40.0%
15,938
-6.4%
0.00%
Q4 2015$60,000
-4.8%
17,030
+6.9%
0.00%
Q3 2015$63,000
-40.6%
15,928
-2.6%
0.00%
Q2 2015$106,000
+19.1%
16,348
+84.2%
0.00%
Q1 2015$89,0008,8740.00%
Other shareholders
HISTOGENICS CORP shareholders Q1 2015
NameSharesValueWeighting ↓
Joseph P. Lucia & Associates, LLC 991$5,730,0000.43%
Abingworth LLP 1,777,778$206,0000.18%
SABBY MANAGEMENT, LLC 1,900,100$220,0000.11%
Rossmore Private Capital 242,004$28,0000.01%
Virtu Financial LLC 592,976$69,0000.00%
Palo Alto Investors LP 302,922$35,0000.00%
Advisor Group, Inc. 100$00.00%
WELLS FARGO & COMPANY/MN 1,000$00.00%
NORTHERN TRUST CORP 20,240$2,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of HISTOGENICS CORP shareholders